Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

1.97
Delayed Data
As of Feb 08
 -0.23 / -10.45%
Today’s Change
1.50
Today|||52-Week Range
5.05
-35.83%
Year-to-Date

Today’s Trading

Previous close2.20
Today’s open2.18
Day’s range1.95 - 2.18
Volume1,754,064
Average volume (3 months)940,145
Market cap$186.6M
Dividend yield--
Data as of 02/08/2016

Growth & Valuation

Earnings growth (last year)-21.43%
Earnings growth (this year)+13.73%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-37.48%
P/E ratioNM
Price/Sales67.02
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AXGNAxoGen Inc0.000.00%
EARSAuris Medical Holdin...+0.15+3.69%
CUTRCutera Inc+0.03+0.29%
DRADDigirad Corp-0.07-1.43%
Data as of 02/08/2016

Financials

Next reporting dateMay 4, 2016
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$5.7M
Annual profit (last year)-$48.0M
Net profit margin-849.13%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts

Partner Offers